Effect of Remifentanil on Electroencephalographic BAR Index During Propofol Anaesthesia

NCT00455026 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2013-05-30

No results posted yet for this study

Summary

Current cortical EEG based depth of anaesthesia monitors do not accurately reflect the effect of opioid drugs. We have developed a new theoretically-based method of analysing the EEG. Our hypothesis is that this new method will more accurately predict depth of anaesthesia than the Bispectral Index (BIS) monitor in patients having elective surgery.

Conditions

  • Depth of Anaesthesia

Interventions

DRUG

remifentanil

target effect site concentration during induction

Sponsors & Collaborators

  • Biopharmica Limited

    collaborator INDUSTRY
  • Melbourne Health

    lead OTHER

Principal Investigators

  • Kate Leslie, MD · Melbourne Health

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00455026 on ClinicalTrials.gov